Drug candidate delivered by plant-virus-based carrier shows promise for triple-negati

[News]

In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.

More... (http://www.news-medical.net/news/20160609/Drug-candidate-delivered-by-plant-virus-based-carrier-shows-promise-for-triple-negative-breast-cancer.aspx)